Spectral Medical Inc T.EDT

Investor Presentation

[Accountprince]

Same old stuff...EXCEPT...in the PMX and Tigris segment...BAXTER logo and name is there for the first time and very prominent!!

So given this presentation is the same old retread with little details changed...is this significant and/or a clue?

Also, the patient number was 23 in Sept 2021 presentation and 30 in March 2022.  Pathetic yes.  Reason to sell to Baxter now...yes and as the MC commercial says...priceless.  Let's see...

So 305 million shares at $10 cdn per share is 3.05B Cdn or $2.4B US. In the right ballpark but some would argue higher.  If we take a one-third discount (thanks Seto and Kellum for the stellar efforts) it's say $6.67 per share cdn or $5.33 US per share.  Overall we get 1.6B US.

[SouthernTierTom]

Thanks AP, why do you think VP Foster was completely overlooked during the companies all- time most generous option / reward dole-out to board members and other inside figures? I will post the US trials.gov update later today, Foster has always been the "contact person" for the phase 3B confirmatory saga. Hard to believe that she arrived at EDT with Walker back in 2001, has been an

[Accountprince]

This reply is speculation only and I absolve myself from it as I wouldn't have handled it this way myself.  End of my preamble to this theoretical and speculative answer... The remuneration of any employee is determined by those in charge...as Foster is a VP it would be by those in higher officer and director positions as influenced/directed by the major shareholders...let's call

[justus434]

This post has been removed in accordance with Community Policy